Overexpression of eis without a mutation in promoter region of amikacin- and kanamycin-resistant Mycobacterium tuberculosis clinical strain

BACKGROUND: Aminoglycosides such as amikacin and kanamycin are effective injectable second-line drugs for treatment of multidrug-resistant tuberculosis. Molecular mechanisms underlying aminoglycoside resistance are not well understood. We have previously identified the amikacin- and kanamycin-resist...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Clin Microbiol Antimicrob
Autors principals: Sowajassatakul, Angkanang, Prammananan, Therdsak, Chaiprasert, Angkana, Phunpruch, Saranya
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6047124/
https://ncbi.nlm.nih.gov/pubmed/30008266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12941-018-0285-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars